To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Hospital-Acquired Infection Control Market size was valued at USD 32,998.89 million in 2022 and is poised to grow from USD 34,007.11 million in 2023 to USD 44,062.37 million by 2031, growing at a CAGR of 7.3% in the forecast period (2024-2031).

The competitive environment of the hospital-acquired infection control market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry. '3M Company', 'Becton, Dickinson and Company', 'STERIS plc', 'Getinge AB', 'Tuttnauer Ltd.', 'Olympus Corporation', 'Xenex Disinfection Services Inc.', 'ASP (Advanced Sterilization Products)', 'Ecolab', 'Belimed AG', 'KCWW (Kimberly-Clark Worldwide, Inc.)', 'MATACHANA GROUP', 'MMM Group', 'Belimed AG', 'Reckitt Benckiser', 'Metrex Research LLC'

In recent years, there has been a substantial upsurge in the count of surgical procedures conducted annually. As per the World Health Organization's data from 2022, an estimated 330 million major surgical procedures are carried out worldwide each year. Several factors contribute to this remarkable increase. The prevalence of conditions like obesity and various lifestyle-related diseases has been steadily rising, necessitating surgical interventions for treatment and management.

Ethylene oxide stands out as one of the most efficient gaseous sterilizing agents, particularly suitable for instruments that are sensitive to high temperatures, such as plastic instruments or those incorporating electrical components. Despite its efficacy, concerns have been raised regarding the potential health risks associated with ethylene oxide exposure.

North America emerged as the dominant force within the market, securing a substantial revenue share exceeding 34.0% in 2022. This commanding presence can be attributed to several key factors shaping the region's healthcare landscape. The region boasts the presence of key industry players actively engaged in combating Hospital Acquired Infections (HAIs) through comprehensive initiatives spanning both public and private sectors.

Feedback From Our Clients

Global Hospital-Acquired Infection Control Market

Product ID: SQMIG35A2598